| Bioactivity | NHS-Modified MMAF (WO2012143499A2, intermediat 210) is an intermediate which can be used for producing the anti-mesothelin binder-drug conjugates (ADCs)[1]. |
| Name | NHS-Modified MMAF |
| CAS | 1404073-10-4 |
| Formula | C55H86N8O12 |
| Molar Mass | 1051.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lerchen HG, et, al. Novel binder-drug conjugates (adcs) and their use. WO2012143499A2. |
NHS-Modified MMAF
CAS: 1404073-10-4 F: C55H86N8O12 W: 1051.32
NHS-Modified MMAF (WO2012143499A2, intermediat 210) is an intermediate which can be used for producing the anti-mesothel
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.